1-3 of 3
Cristiano Ferlini
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Gender Influences the Class III and V β-Tubulin Ability to Predict Poor Outcome in Colorectal Cancer

Available to Purchase
Marisa Mariani, Gian Franco Zannoni, Stefano Sioletic, Steven Sieber, Candice Martino, Enrica Martinelli, Claudio Coco, Giovanni Scambia, Shohreh Shahabi, Cristiano Ferlini
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (10): 2964–2975.
https://doi.org/10.1158/1078-0432.CCR-11-2318
Published: 14 May 2012
View articletitled, Gender Influences the Class III and V β-Tubulin Ability to Predict Poor Outcome in Colorectal Cancer
Open the PDF for Gender Influences the Class III and V β-Tubulin Ability to Predict Poor Outcome in Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

Class III β-Tubulin Overexpression Is a Marker of Poor Clinical Outcome in Advanced Ovarian Cancer Patients

Available to Purchase
Gabriella Ferrandina, Gian Franco Zannoni, Enrica Martinelli, Amelia Paglia, Valerio Gallotta, Simona Mozzetti, Giovanni Scambia, Cristiano Ferlini
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (9): 2774–2779.
https://doi.org/10.1158/1078-0432.CCR-05-2715
Published: 04 May 2006
View articletitled, Class III β-Tubulin Overexpression Is a Marker of Poor Clinical Outcome in Advanced Ovarian Cancer Patients
Open the PDF for Class III β-Tubulin Overexpression Is a Marker of Poor Clinical Outcome in Advanced Ovarian Cancer Patients in another window
Journal Articles

Class III β-Tubulin Overexpression Is a Prominent Mechanism of Paclitaxel Resistance in Ovarian Cancer Patients

Available to Purchase
Simona Mozzetti, Cristiano Ferlini, Paola Concolino, Flavia Filippetti, Giuseppina Raspaglio, Silvia Prislei, Daniela Gallo, Enrica Martinelli, Franco Oreste Ranelletti, Gabriella Ferrandina, Giovanni Scambia
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (1): 298–305.
https://doi.org/10.1158/1078-0432.298.11.1
Published: 21 January 2005
View articletitled, Class III β-Tubulin Overexpression Is a Prominent Mechanism of Paclitaxel Resistance in Ovarian Cancer Patients
Open the PDF for Class III β-Tubulin Overexpression Is a Prominent Mechanism of Paclitaxel Resistance in Ovarian Cancer Patients in another window